The World Health Organization (WHO) announced on May 7 that it has placed the Chinese communist virus (Wuhan pneumonia) vaccine (BBIBP-CorV), developed by Beijing Institute of Biological Products, a subsidiary of Sinopharm, on the organization’s emergency use list. This is the first non-Western-made vaccine against the CCP virus to be certified. However, the effectiveness and safety of the Chinese vaccine has been controversial.
Reuters reported that WHO reviewed two vaccines from China National Pharmaceutical Group and Kexing Biological on the 7th, and finally approved the vaccine from China National Pharmaceutical Group for emergency use.
This is the first time that WHO has approved a Chinese Communist virus vaccine for emergency use against any infectious disease.
WHO has so far approved Pfizer/BNT, AstraZeneca (AZ), Johnson & Johnson (J&J) and Moderna vaccines for emergency use.
At a press conference on the same day, WHO Director-General Tan Desai said that Sinopharm’s vaccine “meets WHO standards for vaccine safety, efficacy and quality”.
Earlier this week, however, other WHO experts had just expressed concern about the quality of the data provided by the company on side effects.
According to WHO standards, vaccines on the emergency use list must be at least 50% effective and preferably close to or above 70%.
In early March, Peruvian media reported that Peruvian Phase III clinical trials found that the effectiveness rate of the Chinese Communist virus vaccine (BBIBP-CorV) developed by Sinopharm’s Beijing Institute of Biological Products was only 11.5%, while another Sinopharm vaccine from Wuhan Institute of Biological Products had an effectiveness rate of only 33%. Sinopharm claims that its vaccine has an efficacy rate of 79%.
A recent evaluation report by the WHO Strategic Advisory Group on Immunization (SAGE) said that the Phase III clinical trial showed that the effectiveness rate of the Chinese vaccine BBIBP-CorV was 78.1%.
But the group also said it had “very little confidence” in the data provided by Chinese state-owned Sinopharm on the risk of side effects of the Sinopharm vaccine. Previously, Sinopharm claimed that the risk of adverse reactions from one or two doses of BBIBP-CorV vaccine was low in people aged 60 years or older, those with comorbidities or those at high risk for COVID-19.
Chinese vaccine expert Tao Lina said in a microblog post earlier this year that the vaccine from the Beijing Institute of Biological Products, known by its trade name “Zhong Ai Ke Wei,” had “drawn a cold breath after reading the adverse side effects, and I counted the ‘adverse reactions I counted 73 kinds of local/systemic adverse reactions”, Taurina said, adding that the Chinese vaccine “has become the world’s most unsafe vaccine in one fell swoop”.
In April this year, according to the microblogging account “Yamashita Hananozi”, his brother is a border police officer, 28 years old. In January this year, after receiving the inactivated vaccine from China National Pharmaceutical Group, he suffered from fatigue and subcutaneous bleeding. In March this year, he was hospitalized with a sudden brain hemorrhage and died on April 15 after being in an ICU coma for more than 20 days. According to “Yamashita Hananozi”, his brother’s unit leaders and Shenzhen Futian authorities told him to “pay attention to the impact” and did not tell him to speak out. The above postings by “Yamashita Hananozi” have all been deleted.
The Chinese medicine vaccine is one of the signboards of the Communist Party’s vaccine diplomacy, but it has also caused many problems abroad.
Philippine President Rodrigo Duterte apologized to the nation on May 6 for his own vaccination, saying, “Don’t follow my example, it’s dangerous,” and asked the Chinese embassy to withdraw the 1,000 doses of the Chinese medicine vaccine given to the Philippines.
In March, Pakistan’s president, defense minister and prime minister were all diagnosed with the Chinese Communist virus after receiving the Chinese medicine vaccine.
Hungary ordered the Chinese medicine vaccine in late January, but the peak of the epidemic resumed in late March, with the number of confirmed cases exceeding 10,000 in a single day. In Seychelles, an African island nation, 60% of the vaccinated population received the national vaccine from late January to mid-April, but the peak of the outbreak occurred in late April.
The WHO is currently evaluating whether another Chinese vaccine, the KeXing vaccine, can also be included in the organization’s emergency use list.
But the Kexing vaccine is also problematic. There have been a number of medical incidents, including deaths from the KeXing vaccine in Hong Kong and outside of China. 22 people have died so far in Hong Kong after receiving the KeXing vaccine, and 32 cases of facial paralysis have occurred after receiving the vaccine.
In Thailand, there have been a number of cases of adverse reactions to the Coxin vaccine, and on April 23, a woman who was in good health died suddenly just two days after receiving the Coxin vaccine.
Questions have been raised about the collusion of the WHO and its director-general, Tan Desai, with the Chinese Communist Party and their role in the pandemic. The German weekly Der Spiegel reported in May 2020 that, according to intelligence from Germany’s Federal Intelligence Service (BND), Xi Jinping spoke with Tan Desai by phone on January 21, 2020, asking him not to release information about human-to-human transmission of the CCP virus and asking him to delay warnings of a CCP virus pandemic.
Former U.S. Secretary of State Mike Pompeo, during a visit to the United Kingdom in July 2020, said outright that Tan had been paid by the Chinese Communist Party.
Recent Comments